Skip to Main Content

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.


And here is our regular feature in which we highlight a different person each week. This time around, we note that Syntimmune hired Dr. Jean-Paul Kress as chief executive officer and president. Previously, he was executive vice president and president, international, and head of global therapeutic operations at Biogen (BIIB).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!